Studies demonstrated that there was an increase in CaV3.2 expression in cell lines with neuroendocrine differentiation compared to prostate cancer, indicating that this channel has a role in morphological and biochemical changes of prostate tumor cells (40). The gene discussed is CACNA1H; the disease is prostate carcinoma.